Applied Therapeutics Company Insiders

APLT Stock  USD 9.63  0.36  3.88%   
Slightly above 86 percent of Applied Therapeutics' insiders are activelly selling. The analysis of the overall insider sentiment regarding Applied Therapeutics suggests that a very large number of insiders are panicking. Applied Therapeutics employs about 37 people. The company is managed by 9 executives with a total tenure of roughly 87 years, averaging almost 9.0 years of service per executive, having 4.11 employees per reported executive.

Applied Therapeutics' Insider Buying Vs Selling

14

 
Selling
 
Buying

Latest Trades

2024-08-14Shoshana ShendelmanDisposed 119591 @ 5.93View
2024-08-12Shoshana ShendelmanDisposed 300000 @ 5.98View
2024-06-06Shoshana ShendelmanDisposed 61795 @ 4.32View
2024-06-04Real Estate Equitie AlexandriaDisposed 150000 @ 4.21View
2024-03-14Shoshana ShendelmanDisposed 318573 @ 5.39View
2023-12-01Stacy J KanterAcquired 30000 @ 2.18View
2023-11-30Riccardo PerfettiDisposed 1583 @ 1.97View
Monitoring Applied Therapeutics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Applied Therapeutics' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Applied Therapeutics' future performance. Based on our forecasts, it is anticipated that Applied will maintain a workforce of slightly above 40 employees by December 2024.
 
Covid

Applied Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.7601) % which means that it has lost $0.7601 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7339) %, meaning that it created substantial loss on money invested by shareholders. Applied Therapeutics' management efficiency ratios could be used to measure how well Applied Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Applied Therapeutics' Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 7.33 in 2024, whereas Return On Tangible Assets are likely to drop (2.29) in 2024. At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 56.5 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 681.3 K in 2024.
Common Stock Shares Outstanding is likely to gain to about 88.5 M in 2024, despite the fact that Net Loss is likely to grow to (90.3 M).

Applied Therapeutics Workforce Comparison

Applied Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,803. Applied Therapeutics holds roughly 37.0 in number of employees claiming about 2.05% of equities under Health Care industry.

Applied Therapeutics Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Applied Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.1667
1
6
 747,886 
 1,561,111 
2024-06-01
1.0
5
5
 480,000 
 400,778 
2023-12-01
1.0
10
10
 5,810,000 
 3,371,516 
2023-09-01
0.25
1
4
 12,375 
 148,659 
2023-03-01
1.0
3
3
 2,814,362 
 26,418 
2022-09-01
1.3529
23
17
 682,266 
 482,522 
2022-06-01
20.0
20
1
 15,278,311 
 905.00 
2022-03-01
4.3333
13
3
 1,013,625 
 319,707 
2021-09-01
0.3
6
20
 48,734 
 141,766 
2021-06-01
0.5526
21
38
 261,464 
 110,601 
2021-03-01
0.3721
16
43
 123,116 
 103,063 
2020-12-01
0.25
9
36
 526,855 
 154,880 
2020-09-01
0.1304
3
23
 36,461 
 233,539 
2020-06-01
0.2917
14
48
 507,603 
 479,512 
2020-03-01
1.5
9
6
 2,228,312 
 2,005,423 
2019-06-01
0.6207
18
29
 5,088,575 
 5,523,618 

Applied Therapeutics Notable Stakeholders

An Applied Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied Therapeutics often face trade-offs trying to please all of them. Applied Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Applied Therapeutics Management Performance

The success or failure of an entity such as Applied Therapeutics often depends on how effective the management is. Applied Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.18)(2.29)
Return On Capital Employed 3.95  4.14 
Return On Assets(2.18)(2.29)
Return On Equity 6.98  7.33 
Please note, the imprecision that can be found in Applied Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied Therapeutics. Check Applied Therapeutics' Beneish M Score to see the likelihood of Applied Therapeutics' management manipulating its earnings.

Applied Therapeutics Workforce Analysis

Traditionally, organizations such as Applied Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied Therapeutics within its industry.

Applied Therapeutics Manpower Efficiency

Return on Applied Therapeutics Manpower

Revenue Per Employee270.1K
Revenue Per Executive1.1M
Net Loss Per Employee3.2M
Net Loss Per Executive13.3M

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.